VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivimed Labs Ltd has submitted its Annual Secretarial Compliance Report for FY 2025-26, as required under SEBI Regulation 24A. The report, issued by Practicing Company Secretary N.V.S.S. Suryanarayana Rao, confirms that the company has largely complied with applicable SEBI regulations including LODR, Prohibition of Insider Trading, and Takeover Regulations. The secretarial auditor verified documents, filings, and website disclosures. One deviation was noted: the company delayed submission of Q3 FY2025 financial results by 25 days. The delay was attributed to the resignation of the Chief Financial Officer on 06.02.2026. BSE and NSE levied a combined fine of Rs. 2,95,000 (including GST Rs. 47,500) for both exchanges. All other compliance areas including secretarial standards, board processes, related party transactions, and document preservation were found satisfactory.
This is a routine compliance filing with a minor regulatory penalty. The Rs. 2.95 lakh fine is relatively small and relates to a one-time delay caused by CFO departure rather than systemic issues. Shareholders can take comfort that the secretarial auditor found no major compliance failures and that the company has proper board processes and compliance mechanisms in place.